These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 14520368)

  • 1. Mutants escape from killer T cells, invade population.
    Wodarz D
    Nat Med; 2003 Oct; 9(10):1254-5. PubMed ID: 14520368
    [No Abstract]   [Full Text] [Related]  

  • 2. Thinking about broadly cross-reactive vaccines.
    Doherty PC; Turner SJ
    Clin Pharmacol Ther; 2009 Jun; 85(6):665-8. PubMed ID: 19404249
    [No Abstract]   [Full Text] [Related]  

  • 3. Mapping the antigenic and genetic evolution of influenza virus.
    Smith DJ; Lapedes AS; de Jong JC; Bestebroer TM; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    Science; 2004 Jul; 305(5682):371-6. PubMed ID: 15218094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening.
    Wang M; Lamberth K; Harndahl M; Røder G; Stryhn A; Larsen MV; Nielsen M; Lundegaard C; Tang ST; Dziegiel MH; Rosenkvist J; Pedersen AE; Buus S; Claesson MH; Lund O
    Vaccine; 2007 Apr; 25(15):2823-31. PubMed ID: 17254671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza drift and epidemic size: the race between generating and escaping immunity.
    Boni MF; Gog JR; Andreasen V; Christiansen FB
    Theor Popul Biol; 2004 Mar; 65(2):179-91. PubMed ID: 14766191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A.
    Gog JR; Rimmelzwaan GF; Osterhaus AD; Grenfell BT
    Proc Natl Acad Sci U S A; 2003 Sep; 100(19):11143-7. PubMed ID: 12954978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
    Rimmelzwaan GF; Boon AC; Voeten JT; Berkhoff EG; Fouchier RA; Osterhaus AD
    Virus Res; 2004 Jul; 103(1-2):97-100. PubMed ID: 15163496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SIRC model and influenza A.
    Casagrandi R; Bolzoni L; Levin SA; Andreasen V
    Math Biosci; 2006 Apr; 200(2):152-69. PubMed ID: 16504214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fitness costs limit escape from cytotoxic T lymphocytes by influenza A viruses.
    Berkhoff EG; de Wit E; Geelhoed-Mieras MM; Boon AC; Symons J; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    Vaccine; 2006 Nov; 24(44-46):6594-6. PubMed ID: 16837112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes.
    Berkhoff EG; de Wit E; Geelhoed-Mieras MM; Boon AC; Symons J; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2005 Sep; 79(17):11239-46. PubMed ID: 16103176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [T-cell growth factor and clonization of type A influenza virus cytotoxic T-cell].
    Lin YL
    Sheng Li Ke Xue Jin Zhan; 1984 Apr; 15(2):126-30. PubMed ID: 6333724
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of natural cytotoxic lymphocytes (natural killers) in the pathogenesis of influenza].
    Trushinskaia GN; Zhdanov VM
    Vopr Virusol; 1988; 33(1):105-10. PubMed ID: 3285590
    [No Abstract]   [Full Text] [Related]  

  • 13. The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity.
    Boon AC; de Mutsert G; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2006 Jun; 80(12):6024-32. PubMed ID: 16731941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update: influenza activity--United States, September 30, 2007-April 5, 2008, and composition of the 2008-09 influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):404-9. PubMed ID: 18418347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic immunity and influenza pandemics.
    Rumyantsev SN
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):1-10. PubMed ID: 16965345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capturing a killer flu virus.
    Taubenberger JK; Reid AH; Fanning TG
    Sci Am; 2005 Jan; 292(1):48-57. PubMed ID: 15724338
    [No Abstract]   [Full Text] [Related]  

  • 17. Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice.
    Cheuk E; Chamberlain JW
    Cell Immunol; 2005 Apr; 234(2):110-23. PubMed ID: 16054612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host species barriers to influenza virus infections.
    Kuiken T; Holmes EC; McCauley J; Rimmelzwaan GF; Williams CS; Grenfell BT
    Science; 2006 Apr; 312(5772):394-7. PubMed ID: 16627737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Back to the future with influenza.
    Griffiths PD
    Rev Med Virol; 2010 Sep; 20(5):263-4. PubMed ID: 20812310
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
    Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
    J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.